Financial results - SCHMIDT PHARMAMED SRL

Financial Summary - Schmidt Pharmamed Srl
Unique identification code: 31040188
Registration number: J16/2039/2012
Nace: 4729
Sales - Ron
145.293
Net Profit - Ron
31.410
Employees
2
Open Account
Company Schmidt Pharmamed Srl with Fiscal Code 31040188 recorded a turnover of 2024 of 145.293, with a net profit of 31.410 and having an average number of employees of 2. The company operates in the field of Comert cu amanuntul al altor produse alimentare, in magazine specializate having the NACE code 4729.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Schmidt Pharmamed Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 3.882 45.411 125.702 166.808 132.887 137.793 119.111 111.568 145.293
Total Income - EUR 0 3.882 45.411 125.702 166.808 132.887 137.793 119.111 132.351 145.293
Total Expenses - EUR 0 4.386 36.035 78.298 99.137 83.682 93.696 93.243 106.888 110.245
Gross Profit/Loss - EUR 0 -504 9.376 47.404 67.671 49.206 44.097 25.868 25.463 35.048
Net Profit/Loss - EUR 0 -582 8.922 46.148 66.003 48.221 43.002 24.705 24.166 31.410
Employees 0 1 1 2 2 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 31.0%, from 111.568 euro in the year 2023, to 145.293 euro in 2024. The Net Profit increased by 7.380 euro, from 24.166 euro in 2023, to 31.410 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Schmidt Pharmamed Srl

Rating financiar

Financial Rating -
SCHMIDT PHARMAMED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Schmidt Pharmamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Schmidt Pharmamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Schmidt Pharmamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Schmidt Pharmamed Srl - CUI 31040188

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 108 424 503 493 2.163 29.720 21.229 1.669 1.393
Current Assets 1.248 5.159 10.924 61.352 76.397 117.691 74.902 14.890 27.773 37.058
Inventories 0 408 7.252 6.566 5.158 5.406 4.790 4.352 9.839 6.055
Receivables 0 3.568 0 875 449 415 445 419 519 25.959
Cash 1.248 1.183 3.672 53.910 70.790 111.871 69.666 10.120 17.415 5.044
Shareholders Funds 1.248 787 9.696 55.666 70.016 116.910 93.110 30.589 24.360 31.604
Social Capital 45 178 175 172 169 165 162 162 162 161
Debts 0 4.480 1.653 6.188 6.873 2.944 11.512 5.530 5.082 6.848
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4729 - 4729"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 37.058 euro in 2024 which includes Inventories of 6.055 euro, Receivables of 25.959 euro and cash availability of 5.044 euro.
The company's Equity was valued at 31.604 euro, while total Liabilities amounted to 6.848 euro. Equity increased by 7.379 euro, from 24.360 euro in 2023, to 31.604 in 2024.

Risk Reports Prices

Reviews - Schmidt Pharmamed Srl

Comments - Schmidt Pharmamed Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.